160 related articles for article (PubMed ID: 25149394)
1. Diagnostic and therapeutic aspects of β1-adrenergic receptor autoantibodies in human heart disease.
Bornholz B; Roggenbuck D; Jahns R; Boege F
Autoimmun Rev; 2014 Sep; 13(9):954-62. PubMed ID: 25149394
[TBL] [Abstract][Full Text] [Related]
2. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease.
Bornholz B; Benninghaus T; Reinke Y; Felix SB; Roggenbuck D; Jahns-Boivin V; Jahns R; Boege F
Clin Chem Lab Med; 2016 Apr; 54(4):683-91. PubMed ID: 26408610
[TBL] [Abstract][Full Text] [Related]
3. Nanodiscs Incorporating Native β1 Adrenergic Receptor as a Novel Approach for the Detection of Pathological Autoantibodies in Patients with Dilated Cardiomyopathy.
Sun R; Mak S; Haschemi J; Horn P; Boege F; Luppa PB
J Appl Lab Med; 2019 Nov; 4(3):391-403. PubMed ID: 31659076
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
[TBL] [Abstract][Full Text] [Related]
5. Relevant effects of beta
Boivin-Jahns V; Jahns R; Boege F
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2146-2156. PubMed ID: 29772551
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.
Buvall L; Bollano E; Chen J; Shultze W; Fu M
Clin Exp Immunol; 2006 Feb; 143(2):209-15. PubMed ID: 16412044
[TBL] [Abstract][Full Text] [Related]
7. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy.
Patel PA; Hernandez AF
Eur J Heart Fail; 2013 Jul; 15(7):724-9. PubMed ID: 23639780
[TBL] [Abstract][Full Text] [Related]
8. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
[TBL] [Abstract][Full Text] [Related]
9. A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.
Li H; Zhang L; Huang B; Veitla V; Scherlag BJ; Cunningham MW; Aston CE; Kem DC; Yu X
J Interv Card Electrophysiol; 2015 Dec; 44(3):205-12. PubMed ID: 26446828
[TBL] [Abstract][Full Text] [Related]
10. The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling.
Mohan ML; Nagatomo Y; Saha PP; Mukherjee SD; Engelman T; Morales R; Hazen SL; Tang WHW; Naga Prasad SV
Mol Biol Cell; 2021 Apr; 32(7):622-633. PubMed ID: 33534612
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β
Nagatomo Y; McNamara DM; Alexis JD; Cooper LT; Dec GW; Pauly DF; Sheppard R; Starling RC; Tang WH;
J Am Coll Cardiol; 2017 Feb; 69(8):968-977. PubMed ID: 28231950
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune basis for postural tachycardia syndrome.
Li H; Yu X; Liles C; Khan M; Vanderlinde-Wood M; Galloway A; Zillner C; Benbrook A; Reim S; Collier D; Hill MA; Raj SR; Okamoto LE; Cunningham MW; Aston CE; Kem DC
J Am Heart Assoc; 2014 Feb; 3(1):e000755. PubMed ID: 24572257
[TBL] [Abstract][Full Text] [Related]
13. Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.
Galloway A; Li H; Vanderlinde-Wood M; Khan M; Benbrook A; Liles C; Zillner C; Rao V; Cunningham MW; Yu X; Kem DC
Endocrine; 2015 Jun; 49(2):457-63. PubMed ID: 25500789
[TBL] [Abstract][Full Text] [Related]
14. Antiadrenergic autoimmunity in postural tachycardia syndrome.
Fedorowski A; Li H; Yu X; Koelsch KA; Harris VM; Liles C; Murphy TA; Quadri SMS; Scofield RH; Sutton R; Melander O; Kem DC
Europace; 2017 Jul; 19(7):1211-1219. PubMed ID: 27702852
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of cross-reacting antibodies anti-β1AR and anti-B13 in advanced stages of Chagas heart disease.
Rodeles LM; Vicco MH; Bontempi IA; Siano A; Tonarelli G; Bottasso OA; Arias P; Marcipar IS
Trop Med Int Health; 2016 Dec; 21(12):1545-1551. PubMed ID: 27699992
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits.
Li H; Zhang G; Zhou L; Nuss Z; Beel M; Hines B; Murphy T; Liles J; Zhang L; Kem DC; Yu X
J Am Heart Assoc; 2019 Oct; 8(19):e013006. PubMed ID: 31547749
[TBL] [Abstract][Full Text] [Related]
17. Unmasking features of the auto-epitope essential for β
Wölfel A; Sättele M; Zechmeister C; Nikolaev VO; Lohse MJ; Boege F; Jahns R; Boivin-Jahns V
ESC Heart Fail; 2020 Aug; 7(4):1830-1841. PubMed ID: 32436653
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.
Jahns R; Boivin V; Siegmund C; Inselmann G; Lohse MJ; Boege F
Circulation; 1999 Feb; 99(5):649-54. PubMed ID: 9950662
[TBL] [Abstract][Full Text] [Related]
19. Inducible cardiac arrhythmias caused by enhanced β1-adrenergic autoantibody expression in the rabbit.
Li H; Scherlag BJ; Kem DC; Benbrook A; Shen X; Cunningham MW; Lazzara R; Aston CE; Yu X
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H422-8. PubMed ID: 24271491
[TBL] [Abstract][Full Text] [Related]
20. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M
Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
